Annual Report 2014 of GlaxoSmithKline (GSK) Bangladesh Limited

It is a broadly described annual report of GlaxoSmithKline (GSK) Bangladesh Limited in the year of 2014. During the year 2014 GlaxoSmithKline Bangladesh Limited contributed to the government exchequer a sum of Tk. 2,356 million, which is a 21% increase over the previous year (2013: Tk. 1,950 million). For the year 2014, The Turnover of the Company was Tk. 7,187 million, 6% higher than last year. The operating profit (after tax) was at Tk. 826 million (51% increase over last year). Net Sales of the Company was Tk 7,187mn, against Tk 6,774mn of last year.  As a result EPS (Earnings per Share) has increased to Tk. 68.63 from Tk. 45.35 in 2013.

The Board of Directors recommended a final dividend of 420% i.e. Tk. 42 per share of Tk. 10.00 each for the year 2014. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of GlaxoSmithKline (GSK) Bangladesh Limited:

  1. Annual Report 2013 of GlaxoSmithKline (GSK) Bangladesh Limited
  2. Annual Report 2014 of GlaxoSmithKline (GSK) Bangladesh Limited
  3. Annual Report 2015 of GlaxoSmithKline (GSK) Bangladesh Limited
  4. Annual Report 2016 of GlaxoSmithKline (GSK) Bangladesh Limited